Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more
Amedisys Inc (AMED) - Total Liabilities
Latest total liabilities as of June 2025: $940.48 Million USD
Based on the latest financial reports, Amedisys Inc (AMED) has total liabilities worth $940.48 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Amedisys Inc - Total Liabilities Trend (1993–2024)
This chart illustrates how Amedisys Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Amedisys Inc Competitors by Total Liabilities
The table below lists competitors of Amedisys Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tegna Inc
NYSE:TGNA
|
USA | $3.69 Billion |
|
Acer Incorporated
PINK:ACEYY
|
USA | $144.73 Billion |
|
CyberAgent Inc
F:CL2
|
Germany | €281.48 Billion |
|
Burberry Group plc
PINK:BBRYF
|
USA | $2.83 Billion |
|
HORIBA Ltd
F:01H
|
Germany | €165.00 Billion |
|
Freshpet Inc
NASDAQ:FRPT
|
USA | $569.12 Million |
|
Sandstorm Gold Ltd N
NYSE:SAND
|
USA | $376.30 Million |
|
Doximity Inc
NYSE:DOCS
|
USA | $177.73 Million |
Liability Composition Analysis (1993–2024)
This chart breaks down Amedisys Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Amedisys Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Amedisys Inc (1993–2024)
The table below shows the annual total liabilities of Amedisys Inc from 1993 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $958.75 Million | +1.95% |
| 2023-12-31 | $940.39 Million | +8.13% |
| 2022-12-31 | $869.67 Million | -1.25% |
| 2021-12-31 | $880.64 Million | +16.42% |
| 2020-12-31 | $756.46 Million | +21.77% |
| 2019-12-31 | $621.23 Million | +164.93% |
| 2018-12-31 | $234.49 Million | -21.06% |
| 2017-12-31 | $297.06 Million | +8.86% |
| 2016-12-31 | $272.89 Million | -0.64% |
| 2015-12-31 | $274.65 Million | +0.98% |
| 2014-12-31 | $271.98 Million | -23.15% |
| 2013-12-31 | $353.93 Million | +28.07% |
| 2012-12-31 | $276.36 Million | -18.27% |
| 2011-12-31 | $338.14 Million | -19.51% |
| 2010-12-31 | $420.11 Million | -3.65% |
| 2009-12-31 | $436.02 Million | -14.18% |
| 2008-12-31 | $508.08 Million | +264.76% |
| 2007-12-31 | $139.29 Million | +39.64% |
| 2006-12-31 | $99.75 Million | -32.33% |
| 2005-12-31 | $147.40 Million | +187.55% |
| 2004-12-31 | $51.26 Million | +24.80% |
| 2003-12-31 | $41.07 Million | -0.69% |
| 2002-12-31 | $41.36 Million | -6.56% |
| 2001-12-31 | $44.27 Million | +1.78% |
| 2000-12-31 | $43.49 Million | -16.67% |
| 1999-12-31 | $52.19 Million | -6.82% |
| 1998-12-31 | $56.01 Million | +283.89% |
| 1997-12-31 | $14.59 Million | +18.08% |
| 1996-12-31 | $12.36 Million | +71.61% |
| 1995-12-31 | $7.20 Million | +75.61% |
| 1994-12-31 | $4.10 Million | +70.83% |
| 1993-12-31 | $2.40 Million | -- |